Please use this identifier to cite or link to this item:
Title: Effect of passively transferred anti-poliovirus antibodies on seroconversion.
Authors: Bavdekar, S B
Naik, S
Nadkarni, S S
Kamat, J R
Deshpande, J M
Vaswani, L K
Issue Date: 8-Jan-1999
Citation: Bavdekar SB, Naik S, Nadkarni SS, Kamat JR, Deshpande JM, Vaswani LK. Effect of passively transferred anti-poliovirus antibodies on seroconversion. Indian Journal of Pediatrics. 1999 Jan-Feb; 66(1): 45-8
Abstract: A prospective study enrolling 50 mother-infant pairs was undertaken to determine the effect of maternal antibodies on poliovirus antibody titres and seroconversion rates in infants and to determine the difference in titres and seroconversion rates following three and five doses of oral poliovaccine (OPV). Cord blood samples and samples collected 4 weeks after 3rd and 5th doses of trivalent oral poliovaccine were processed for estimation of anti-poliovirus antibody titres. These were expressed as geometric mean titres (GMT). Significance was analyzed using unpaired 't' test. The relationship between maternal antibody titres and seroconversion was determined by correlation coefficient test. Post OPV5 titres were significantly higher than post OPV3 titres for type 1 and type 2 polioviruses. Seroconversion rates against type 1, 2 and 3 polioviruses were 92.9%, 100.0% and 92.9% following OPV3 and 100.0%, 100.0% and 93.2% following OPV5. The cord blood titres did not have any relation to post-OPV3 or post-OPV5 titres. Although there is significant passive transfer of poliovirus antibodies across the placenta, this does not affect titres achieved after immunization. Post-OPV5 titres against type 1 and type 2 viruses are significantly higher than post-OPV3 titres. The seroconversion rates following OPV5 are higher than those obtained post-OPV3 but this difference is not statistically significant.
Appears in Collections:Indian Journal of Pediatrics

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.